International external environment

• Recession brought on by the COVID-19 pandemic
• Downgrades to GDP growth forecasts in western Europe, UK and Poland
• Ongoing uncertainty regarding the implications of Brexit

• Maximising efficiencies
• Ensuring technical excellence
• Resuming growth initiatives once appropriate

• Exposure to exchange rates
• Volatile exchange rates affecting the procurement of medical equipment, as well as the conversion of earnings into our reporting currency

• Capturing opportunities to enhance efficiencies
• Strengthening relationships with suppliers
• Sourcing products and services in the local currency

• Increased competition for patients and technology
• Scarcity of skilled healthcare professionals

• Differentiating service offerings
• Improving cost efficiencies
• Building long-term relationships with stakeholders
• Engaging with global partners and universities
• Developing training programmes to attract graduates
• Enhancing our EVP

• Population growth
• Increased life expectancy
• Changing demographics
• Rapid urbanisation
• Increased prevalence of chronic health conditions

• Investing in long-term, cost-effective solutions
• Enhancing the quality of care
• Improving patient experiences

• Pressure from public and private funders to contain costs

• Focusing on driving efficiencies
• Effectively leveraging our resources
• Strengthening relationships with stakeholders

• Lockdown restrictions imposed by governments across Europe
• Self-isolation and social distancing guidelines of the various regions where we operate
• Increases in patient cancellations and suspension of elective procedures
• Increased focus on leveraging technology to deliver care to patients

• Tailoring our COVID-19 response to country-specific requirements
• Supporting governments
• Responding to pent-up demand from COVID-19 backlog
• Ensuring adequate PPE for employees and doctors

  Refer to Our response to COVID-19 for more information on our response to COVID-19.